More than 1,300 lobbyists roamed the halls of Congress on the 21st Century Cures Act, and disclosure reports show most of them were working for pharmaceutical companies.
By Sheila Kaplan, STAT
The superbug is a reminder of the unintended consequences of the modern quest for productivity. Barring a solution, it will take an enormous toll.
By Vikram Mansharamani
The absence of drug-pricing proposals from the GOP contenders illustrates how hard it would be for Sanders or Clinton to get Congressional approval should they win office.
By Philip Moeller
After outrage from the public and even presidential candidates, Turing Pharmaceuticals has announced it will reduce the price of the drug whose cost had previously increased by more than 5,000 percent practically overnight.
By Michelle Harven
By Megan Thompson
Pharmaceutical maker Teva has agreed to a settlement of $512 million in a class action lawsuit over the wakefulness drug Provigil. Drug wholesalers and retailers claimed a generic version of the drug was delayed to market by so-called “pay for…
On the eve of the president's State of the Union address and the World Economic Forum, Oxfam is predicting a widening wealth gap and pointing a finger at the millions of dollars spent on lobbying in the United States for…
By Lauran Neergaard, Associated Press
The Liberian government said Monday that it will receive doses of the drug to treat two doctors in the country. They would be the first Africans to receive it.
By Mary Clare Jalonick, Associated Press
The Food and Drug Administration says 25 pharmaceutical companies are voluntarily phasing out the use of antibiotics for growth promotion in animals processed for meat.
By PBS NewsHour
On this edition, a rare alliance brings major drug companies together to fight serious diseases like diabetes and rheumatoid arthritis. Later, in our signature segment, a financially strapped city struggles to fulfill its obligations to retired public employees. And, a…
Support Provided By: Learn more